News and insights into the #2 pharma/medtech market - China

Greg B. Scott founded ChinaBio® in 2007 to help western life science companies achieve success in China. ChinaBio® is a consulting and advisory firm based in Shanghai that has helped over 100 U.S., European and APAC companies seeking partnerships, acquisitions, novel ... more

ALL CONTRIBUTIONS

Week In Review: Zai Lab Targets $1 Billion Valuation In Planned US IPO
Shanghai's Zai Lab is planning a US IPO that could raise $150 million and value the company at $1 billion. The company has already picked Citigroup and JPMorgan Chase as underwriters, though it has not completed a US filing.
Read
Week In Review: China VC/PE Funds Raising Capital At $30 Billion Rate In 2017
China life science venture/private equity funds have raised $45 billion and invested $12 billion over the past 30 months. They closed $20 billion in new funds during 2016 and are on track to hit $30 billion this year.
Read
Week In Review: Vivace Details Its Capital Efficient Plan To Develop Novel Cancer Therapies
In June, Vivace Therapeutics burst its stealth bubble by announcing it had raised $40 million in venture capital.
Read
Week In Review: C-Bridge Raises $400 Million For Second China Healthcare Fund
C-Bridge plans to invest in late-stage companies in the fields of bio-technology, pharmaceuticals, medical devices and health care, particularly those with cross-border ambitions.
Read
Week In Review: BGI Genomics Completes $81 Million Chi-Next IPO
BGI Genomics, a Shenzhen sequencing and diagnostics company, completed an $81 million IPO Friday on Shenzhen's Chi-Next exchange, offering 40.1 million shares at 13.64 RMB per share.
Read
Week In Review: Beigene Sets Record With $1.4 Billion Celgene Deal
BeiGene of Beijing has entered a "transformational" collaboration with Celgene which involves BeiGene's clinical-stage PD-1 immuno-oncology drug, has a total value of almost $1.4 billion.
Read

STOCKS I FOLLOW

AXN Aoxing Pharmaceutical Company, Inc.
CRPNF China Pioneer Pharma Holdings Ltd.
CYIG CHINA YCT INTL GROUP
HCM Hutchison Chi-Med
ICLR Icon PLC
MCRPF MICROPORT SCIENTIFIC
MDCO The Medicines Company
MR Mindray Medical International Limited
NBY NovaBay Pharmaceuticals, Inc.
SCLN SciClone Pharmaceuticals, Inc.
WX WuXi PharmaTech Inc.
Load More

TWEETS

LATEST ACTIVITY

ChinaBio® Today
Week in Review: Zai Lab Targets $1 Billion Valuation in Planned US IPO $BIOC https://t.co/cbKbIHqbpi...

ChinaBio® Today
Week In Review: China VC/PE Funds Raising Capital At $30 Billion Rate In 2017 $GSK $GSK $HCM https://t.co/8HlPJ8qCdC less
ChinaBio® Today
Week In Review: Vivace Details Its Capital Efficient Plan To Develop Novel Cancer Therapies $DMPI $DMPI $SRTS https://t.co/CZnTI3BKo3 less
All Posts

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications